Highlights Windlas Biotech Limited

Equities

WINDLAS

INE0H5O01029

Market Closed - NSE India S.E. Other stock markets 07:58:35 2024-06-07 am EDT			5-day change	1st Jan Change
664 ^INR	-0.09%		+5.05%	+54.87%

May. 20	Windlas Biotech Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024	CI
May. 20	Windlas Biotech Limited Reports Earnings Results for the Full Year Ended March 31, 2024	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Windlas Biotech Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024	May. 20	CI
Windlas Biotech Limited Reports Earnings Results for the Full Year Ended March 31, 2024	May. 20	CI
Windlas Biotech Commissions New Injectible Manufacturing Unit	Apr. 02	MT
Windlas Biotech Limited Commissions Its Injectable Facility	Apr. 02	CI
Windlas Biotech Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	Feb. 08	CI
Windlas Biotech Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	Feb. 08	CI
Windlas Biotech Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	Nov. 08	CI
Windlas Biotech Limited Approves Final Dividend for the Financial Year 2022-23	23-09-12	CI
Windlas Biotech Limited Proposes Final Dividend for the Financial Year 2022-23	23-08-18	CI
Windlas Biotech Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	23-08-08	CI
Windlas Biotech's Consolidated Profit Slips in Fiscal Q4	23-05-08	MT
Windlas Biotech Limited Reports Earnings Results for the Full Year Ended March 31, 2023	23-05-05	CI
Windlas Biotech Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2023	23-05-05	CI
Windlas Biotech Limited Recommends Dividend	23-05-05	CI
Tranche Update on Windlas Biotech Limited's Equity Buyback Plan announced on November 8, 2022.	23-05-05	CI
Tranche Update on Windlas Biotech Limited's Equity Buyback Plan announced on November 8, 2022.	23-05-03	CI
Windlas Biotech Limited's Equity Buyback announced on November 8, 2022 has closed with 867,747 shares, representing 3.98% for INR 217.97 million.	23-05-02	CI
Windlas Biotech's Consolidated Profit Climbs in Fiscal Q3	23-02-09	MT
Windlas Biotech Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	23-02-08	CI
Tranche Update on Windlas Biotech Limited's Equity Buyback Plan announced on November 8, 2022.	23-02-08	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Windlas Biotech Limited

Equities

WINDLAS

INE0H5O01029

Highlights

Filters